Physician profile
Patrick D Jenkins
NPI 1548764509
$896.85
in general payments reported to CMS, 2019-2025
17 companies · $696 in 2025
The $696 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.24 · 2020: $37.73 · 2021: $21.29 · 2024: $114 · 2025: $696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $792 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $792.21 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $237.73 | 2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $109.09 | 2024-2025 | Fasenra, Airsupra, Breztri |
| Insmed, INC. | $92.45 | 2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $82.16 | 2025 | Dupixent |
| Amgen INC. | $60.45 | 2020-2025 | Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.27 | 2025 | |
| Baxter Healthcare | $35.40 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Abbvie INC. | $35.22 | 2021-2025 | |
| Verona Pharma, INC. | $30.42 | 2025 | Ohtuvayre |
| Novo Nordisk INC | $28.24 | 2019 | |
| Genzyme Corporation | $27.06 | 2024 | |
| Mylan Specialty L.P. | $26.44 | 2024 | Yupelri |
| United Therapeutics Corporation | $25.20 | 2024 | Tyvaso |
| Mallinckrodt Hospital Products INC. | $22.95 | 2025 | Acthar |
| Viatris Specialty LLC | $16.06 | 2025 | Yupelri |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $15.11 | 2025 | Vest Therapy Und |
| Bayer Healthcare Pharmaceuticals INC. | $13.60 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Jenkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.